Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Plasminogen Activator Inhibitor-1 (PAI-1)-Tranexamic acid
Tranexamic acid

Chemical Structure : Tranexamic acid

CAS No.: 1197-18-8

Tranexamic acid (TXA)

Catalog No.: PC-24263Not For Human Use, Lab Use Only.

Tranexamic acid (Cyclocapron) is a cyclic analog of lysine and orally active antifibrinolytic agent, inhibits urokinase plasminogen activator (uPA) and ameliorates dry wrinkles, attenuates the effects of severe trauma.

Packing Price Stock Quantity
1 g $28 In stock
5 g $48 In stock
10 g Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Tranexamic acid (Cyclocapron) is a cyclic analog of lysine and orally active antifibrinolytic agent, inhibits urokinase plasminogen activator (uPA) and ameliorates dry wrinkles, attenuates the effects of severe trauma.

Physicochemical Properties

M.Wt 157.21
Formula C8H15NO2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

trans-4-(aminomethyl)cyclohexane-1-carboxylic acid

References

1. Prudovsky I, et al. Journal of cellular physiology, 2019, 234(11): 19121-19129.

2. Wu G, et al. Blood advances, 2019, 3(5): 729-733.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: